MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

13 Aug 2024 Evaluate
The sales surged to Rs. 808.24 millions, up 40.61% for the June 2024 quarter as against Rs. 574.80 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 237.97% to Rs. 20.65  millions from Rs. 6.11 millions in the previous quarter.OP of the company witnessed a marginal growth to 31.70 millions from 11.35 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 808.24 574.80 40.61 808.24 574.80 40.61 2815.81 3106.46 -9.36
Other Income 5.86 3.64 60.99 5.86 3.64 60.99 13.85 4.78 189.75
PBIDT 31.70 11.35 179.30 31.70 11.35 179.30 38.54 244.06 -84.21
Interest 1.91 2.20 -13.18 1.91 2.20 -13.18 6.87 12.32 -44.24
PBDT 29.79 9.15 225.57 29.79 9.15 225.57 31.67 231.74 -86.33
Depreciation 1.61 1.62 -0.62 1.61 1.62 -0.62 6.47 6.43 0.62
PBT 28.18 7.53 274.24 28.18 7.53 274.24 25.20 225.31 -88.82
TAX 7.53 1.42 430.28 7.53 1.42 430.28 3.57 59.00 -93.95
Deferred Tax 1.53 -0.49 -412.24 1.53 -0.49 -412.24 0.82 -2.07 -139.61
PAT 20.65 6.11 237.97 20.65 6.11 237.97 21.63 166.31 -86.99
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 3.92 1.97 98.63 3.92 1.97 98.63 1.37 7.86 -82.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..